Active Pharmaceutical Ingredients (API) Market to Exhibit 6.1% CAGR; Rising Demand for Biosimilar & Biologics to Drive Growth: Fortune Business Insights™

USA - English

• India - English

PUNE, India, April 20, 2020 /PRNewswire/ -- The global active pharmaceutical ingredient (API) market is set to gain impetus from the rising implementation of strict norms and regulations in several countries regarding the production of high-quality API. It is further aiding in upsurging the overhead costs of in-house API manufacturing. Therefore, numerous pharmaceutical companies are focusing on outsourcing the manufacturing. This information is provided by Fortune Business Insights™ in a recent report, titled, "Active Pharmaceutical Ingredients (API) Market Size, Share & Industry Analysis, By Type (Generic API, and Branded API), By Synthesis (Biological API, and Synthetic API), and Regional Forecast, 2019-2026." The report further mentions that the API market size stood at USD 164.20 billion in 2018 and is projected to reach USD 261.28 billion by 2026, exhibiting a CAGR of 6.1% during the forecast period.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/active-pharmaceutical-ingredient-api-market-102656

This Report Answers the Following Questions:

An Overview of the Impact of COVID-19 on this Market:

• What are the recent API market trends that are affecting the market?
• Which are the top companies present in the market?
• How many companies have signed new contracts and agreements?
• What type of multi-year and annual collaborations are the organizations exploring?
• What are the major growth drivers, challenges, and opportunities?

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

To get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/active-pharmaceutical-ingredient-api-market-102656

Drivers & Restraints-

High Demand for Novel Drugs to Boost Growth

The Indian Brand Equity Foundation (IBEF) mentioned that during 2015 to 2020, the pharmaceutical industry of India is set to exhibit a considerable CAGR of 22.4%. As per one of our lead analysts, "The incidence of chronic diseases is surging at a fast pace worldwide backed by the rising geriatric population. Rapid urbanization, as well as increasing adoption of sedentary lifestyle would also contribute to the growth."  Apart from that, there is an alarming rise in the number of new cases of chronic diseases. It is therefore, skyrocketing the demand for state-of-the-art drugs. High demand for biosimilars and biologics would hence, propel the active pharmaceutical ingredient market growth in the coming years. However, changes in price policies in the developing nations may hamper growth.

Segment-

Synthetic API Segment to Grow Steadily Backed by their Cost-effective Nature

Based on synthesis, the market is bifurcated into biological API and synthetic API. Out of these, the synthetic API segment led in terms of API market share in 2018 backed by the cost-effective nature of raw materials used for producing these APIs. They are cheaper than the biological API. The biological API segment is anticipated to grow considerably throughout the forecast period on account of the rising technological advancements in biologics, as well as high demand for biopharmaceuticals to treat many diseases. Additionally, the surging number of FDA approvals for biological drugs, namely, recombined proteins, blood components, and vaccines would contribute to the growth of this segment.

Quick Buy -  Active Pharmaceutical Ingredients Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102656

Regional Analysis-

Presence of Many Contract Manufacturing Organizations to Favor Growth in Asia Pacific

In terms of region, the market is divided into Asia Pacific, Europe, Latin America, the Middle East and Africa, and North America. Amongst these, in 2018, North America procured USD 79.80 billion API market revenue. This growth is attributable to the rising government initiatives to develop unique drugs, as well as the rising prevalence of chronic diseases in this region.

Asia Pacific, on the other hand, is expected to outpace Europe and North America in the near future because of the rising number of pharmaceutical industries and contract manufacturing organizations present in the developing countries, such as India and China. Owing to the availability of raw material in abundance and lower labour cost, these countries have started becoming major venues for outsourcing API manufacturing. Also, several manufacturers have implemented favourable regulatory policies in this region to broaden their production capacity. It would also boost growth.

Competitive Landscape-

Key Players Focus on Developing Various APIs to Boost Sales

The market includes many contract manufacturing organizations that are mainly aiming to develop biological APIs. Companies located mainly in Asia Pacific are focusing on creating generic APIs. But, key players situated in North America and Europe are moving towards the development of biological API. Below are a couple of the recent industry developments:

• January 2020: Astellas Pharma Inc. developed its brand new API manufacturing facility for a first-line immunosuppressant called Prograf. It will be used for organ transplantation.
• June 2016: AbbVie Inc. widened its small molecule API facility located in Singapore to strengthen its position in women's health and oncology sectors.

List of the Key Companies operating in the Active Pharmaceutical Ingredients Market. They are as follows:

• Aurobindo Pharma
• Teva Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories Ltd.
• Mylan N.V.
• AbbVie Inc.
• Sun Pharmaceutical Industries Ltd.
• Abbott   
• Biocon
• Cipla Inc.
• Amgen Inc.
• Other key market players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/active-pharmaceutical-ingredient-api-market-102656

Detailed Table of Content:

• Introduction
• Research Scope
• Market Segmentation
• Research Methodology
• Definitions and Assumptions
• Executive Summary
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Key Insights
• Prevalence of Chronic Diseases -2018
• New Product Launches by Key Players
• Recent Industry Developments- Partnerships, Mergers, And Acquisitions
• Therapeutic Applications of the Different Types of Active Pharmaceutical Ingredient
• Global Active Pharmaceutical Ingredient (API) Market Analysis, Insights and Forecast, 2015-2026
• Key Findings / Summary
• Market Analysis, Insights and Forecast – By Type
• Generic API
• Branded API
• Market Analysis, Insights and Forecast – By Synthesis
• Biological API
• Synthetic API
• Market Analysis, Insights and Forecast – By Region
• North America
• Europe
• Asia Pacific
• Rest of World

TOC Continued….!

Request  for Customization:  https://www.fortunebusinessinsights.com/enquiry/customization/active-pharmaceutical-ingredient-api-market-102656

Have a Look at Related Reports:

Contract Research Organization (CRO) Services Market Size, Share and Global Trend By Service Type (Discovery, Pre-Clinical, Clinical, Laboratory Services), By Application (Oncology, Cardiology, Infectious Disease, Metabolic Disorders), By End User(Pharmaceutical & Biotechnological Companies, Medical Device Companies, Academic & Research Institutes) and Geography Forecast till 2026

Genomics Market Size, Share and Global Trend By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing), Application (Diagnostics, Research), End-User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs)) & Geography Forecast till 2026

Next-Generation Sequencing (NGS) Market Size, Share and Global Trend By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Geography Forecast till 2026

Contract Development and Manufacturing Organization (CDMO) Market Size, Share & Industry Analysis, By Service {By CMO (API, Finished Product {Solid Dosage Forms, Injectables, and Others}, and Packaging)} {By CRO (Discovery, Preclinical, Clinical Trial, and Laboratory Services)} and Regional Forecast, 2019-2026

Contract Manufacturing Organization (CMO) Market Size, Share & Industry Analysis, By Type (API Manufacturing, Finished Dosage Form Manufacturing (Solid Dosage Forms, Injectables, and Others), and Packaging), and Regional Forecast, 2019-2026

Cancer Biomarkers Market Size, Share & Industry Analysis, By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, and Others), By Biomarker Type (PSA, HER-2, EGFR, KRAS, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026.

Regenerative Medicine Market Size, Share and Industry Analysis By Product (Cell Therapy, Gene Therapy, Tissue Engineering, Platelet Rich Plasma), By Application (Orthopaedics, Wound Care, Oncology), By Distribution Channel (Hospitals, Clinics) & Regional Forecast, 2019 – 2026

Biobanking Market Size, Share & Industry Analysis, By Sample Storage (Blood, Cells & Tissue, and Others), By Application (Regenerative Medicines, Life Sciences, and Others), By Settings (Academic Medical Institutes, and Pharmaceutical & Biotechnology Companies), and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US: +1-424-253-0390
UK:  +44-2071-939123
APAC: +91-744-740-1245
Email: [email protected]

Fortune Business Insights™

LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/active-pharmaceutical-ingredient-api-market-9792

SOURCE Fortune Business Insights